0086 532 85065286 THOMASQIAO@KINGWISH.CN Qingdao, Shandong, China

Albendazole (Pharma Grade)

Products / Albendazole (Pharma Grade)

Albendazole molecular structure
Quick Facts
CAS Number54965-21-8
Molecular FormulaC12H15N3O2S
Molecular Weight265.33
PharmacopoeiaCP/USP
Packaging25 KG/DRUM
Pharma Grade WHO Essential Medicine CP/USP

Product Overview

Albendazole is a broad-spectrum benzimidazole anthelmintic listed on the WHO Model List of Essential Medicines. It exerts its antiparasitic effect by binding to parasite beta-tubulin, inhibiting microtubule polymerization and disrupting glucose uptake, leading to parasite energy depletion and death.

This pharmaceutical-grade Albendazole demonstrates proven efficacy against a wide range of intestinal and tissue parasites. It is effective against roundworms (Ascaris lumbricoides), hookworms (Ancylostoma duodenale, Necator americanus), whipworms (Trichuris trichiura), and tissue parasites including Echinococcus granulosus (hydatid disease) and Taenia solium (neurocysticercosis).

Quality Specifications

PurityAs per CP/USP monograph
Residual SolventsCompliant with ICH Q3C
Heavy MetalsCompliant with pharmacopoeia limits
GMP StatusManufactured under GMP conditions

Pharmaceutical Applications

Oral Tablets (400mg)

Standard 400mg tablet for single-dose mass drug administration in soil-transmitted helminth control programs.

Oral Suspension

200mg/5ml and 400mg/10ml suspensions for pediatric deworming and patients unable to swallow tablets.

Therapeutic Indications

  • Soil-Transmitted Helminth Infections: Roundworm, hookworm, and whipworm infections
  • Neurocysticercosis: Treatment of parenchymal neurocysticercosis caused by Taenia solium larvae
  • Hydatid Disease: Pre- and post-surgical treatment of cystic echinococcosis
  • Lymphatic Filariasis: In combination with ivermectin for mass drug administration programs
  • Giardiasis: Alternative treatment for giardiasis in children
Inquire About This Product Back to Products